← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 1989Last known activity
Sep 14, 2021
Timeline
1970s
- Jun 1, 1977
Children's Cancer and Leukaemia Group— Founded
Drugs by trial phase (52 distinct, 49 trials)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Central Nervous System Neoplasms
- Ependymoma
- Glioma
- Hepatoblastoma
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- Intestinal Neoplasms
- Kidney Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Liver Neoplasms
- Lymphohistiocytosis, Hemophagocytic
- Lymphoma
- Medulloblastoma
- Neoplasms
- Neoplasms, Germ Cell and Embryonal
- Nervous System Neoplasms
- Neuroblastoma
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Clear Cell
- Sarcoma, Ewing
- Wilms Tumor
Recent trials (49)
- NCT05425043CollaboratorN/ASep 14, 2021
- NCT00939965Lead sponsorN/AFeb 1, 2009
- NCT00389766Lead sponsorPhase 2Jul 1, 2008
- NCT00392340Lead sponsorPhase 2Mar 1, 2008
- NCT00514397Lead sponsorPhase 2Jan 1, 2008
- NCT00652132Lead sponsorPhase 3Dec 1, 2007
- NCT00513981Lead sponsorPhase 1Mar 1, 2007
- NCT00417053Lead sponsorPhase 3Dec 27, 2006
- NCT00416676Lead sponsorPhase 3Dec 27, 2006
- NCT00417014Lead sponsorN/ADec 27, 2006
- NCT00416377Lead sponsorN/ADec 27, 2006
- NCT00365755Lead sponsorPhase 3Aug 16, 2006
- NCT00379457CollaboratorPhase 3Jun 1, 2006
- NCT00334672Lead sponsorPhase 3Mar 1, 2006
- NCT00334854CollaboratorPhase 3Mar 1, 2006
Details
- Founded
- Leicester, GB Jun 1, 1977
- Last known activity
- Sep 14, 2021